Endocarditis, Bacterial clinical trials
The registry lists 22 studies for Endocarditis, Bacterial across more than 10 countries. 9 are recruiting or about to start. 18 of them are mainly about Endocarditis, Bacterial (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the Endocarditis, Bacterial studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2) · Fondation Hôpital Saint-Joseph (2) · University of Aarhus (1) · University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba) (1) · Charles University, Czech Republic (1) · Assistance Publique - Hôpitaux de Paris (1) · Laura Fanucchi (1) · Infectopharm Arzneimittel GmbH (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
Who these studies take
Of the 5 Endocarditis, Bacterial studies recruiting now, 4 (80%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (20%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 5 (100%) | 5 (100%) |
| 30 | 5 (100%) | 5 (100%) |
| 40 | 5 (100%) | 5 (100%) |
| 50 | 5 (100%) | 5 (100%) |
| 65 | 5 (100%) | 5 (100%) |
| 75 | 5 (100%) | 5 (100%) |
| 85 | 5 (100%) | 5 (100%) |
Across all 22 studies, recruiting or not: 9% stop at 75 or younger and 9% at 65; 14% take children; 0% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Studies
Recruiting first, then most recently updated. Showing 22 of 22. search them.
- A Study of Ceftobiprole Compared With Standard Antibiotic Treatment in Children With Staphylococcus Aureus Bacteremia (SAB) Infection, Including Right-sided Heart InfectionNot yet recruitingNCT07929493Phase 3
- AngioVac Aspiration Therapy RegistryNot yet recruitingNCT077693201 country
- New Treatment of Cardiac Device Infections; Immediate Reimplantation After Removal of Infected SystemRecruitingNCT06250985Phase 31 country
- Barts Endocarditis Research RegistryRecruitingNCT064340121 country
- Dalbavancin Therapy for Infective EndocarditisNot yet recruitingNCT07699211Phase 31 country
- Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective EndocarditisRecruitingNCT06870409Phase 31 country
- Fosfomycin I.v. for Treatment of Severely Infected PatientsRecruitingNCT029799515 countries
- T2MR PCR Detection of ESKAPE Pathogens in Patients With Pyogenic Spondylodiscitis and Infective EndocarditisRecruitingNCT056449901 country
- Effectiveness of Antibiotic Prophylaxis of Infective Endocarditis for Invasive Dental Procedures in Patients With Prosthetic Heart Valves and/or History of Infective EndocarditisNot yet recruitingNCT05613933Not applicable
- Endocarditis Clinical Awareness, Research, and Evaluation in SwedenActive, not recruitingNCT076711181 country
- Combined Rehabilitation and Nutritional Support vs. Standard Care in In-Hospital Endocarditis TreatmentTerminatedNCT06563609Not applicable1 country
- Anemia in Patients With EndocarditisCompletedNCT048402251 country
- Short-course Antibiotic Treatment in Gram-positive Cocci Infective EndocarditisTerminatedNCT04222257Phase 41 country
- Predictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly Staphylococcus Aureus Bacteriuria, and Time to Blood Culture PositivityStatus unknownNCT055227641 country
- Neurological Complication of Infective Endocarditis: A Prospective Multi-site Cohort StudyStatus unknownNCT05152225
- Characterization of Endocarditis to Streptococci and Impact of the CMI on the Future of the PatientsCompletedNCT033062251 country
- Combining Opioid Addiction Treatment Services With CARe for Infectious EndocarditisCompletedNCT03048643Not applicable1 country
- Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA BacteremiaTerminatedNCT00695903Phase 21 country
- Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.TerminatedNCT00401960Phase 41 country
- Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. AureusCompletedNCT00093067Phase 3
- How to Improve Diagnosis in Infective EndocarditisCompletedNCT005242121 country
- IMAGE-Endocarditis: Resonance Magnetic Imaging at the Acute Phase of EndocarditisCompletedNCT00144885Not applicable1 country